Disease Modifying Treatments
Showing 1 - 25 of >10,000
Long Term Trajectories of SMA Patients Receiving or Not
Recruiting
- Spinal Muscular Atrophy
-
Genova, Italy
- +4 more
Mar 2, 2023
MAP THE SMA:Machine-learning Based Algorithm to Predict
Not yet recruiting
- Spinal Muscular Atrophy
- disease modifying treatments
- (no location specified)
Mar 14, 2023
Multiple Sclerosis Trial in Atlanta, Worcester, Salt Lake City (IMS001)
Recruiting
- Multiple Sclerosis
- IMS001
-
Atlanta, Georgia
- +2 more
Sep 20, 2021
Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo
Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))
Suspended
- Alzheimers Disease
- +2 more
- Gantenerumab
- Matching Placebo (Gantenerumab)
-
Birmingham, Alabama
- +34 more
Jan 10, 2023
Neurological Disorder, Autoimmune Diseases Trial in Canada, United States (Mycophenolate Mofetil, Azathioprine)
Completed
- Neurological Disorder
- Autoimmune Diseases
- Mycophenolate Mofetil
- Azathioprine
-
Palo Alto, California
- +18 more
Feb 2, 2021
Describe Switching FromFirst- or Second-line Disease Modifying
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- (no location specified)
Dec 12, 2022
Parkinson Disease Trial in Roma (Physical activity training)
Recruiting
- Parkinson Disease
- Physical activity training
-
Roma, ItalyFlavia Torlizzi
Apr 4, 2023
C10.114.375.500 Trial in Lille, Caen, Rouen (Delay between MS onset and introduction of first line DMT, EDI)
Completed
- C10.114.375.500
- Delay between MS onset and introduction of first line DMT
- EDI
-
Lille, Hauts-de-France, France
- +3 more
Oct 20, 2020
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified
Not yet recruiting
- Coronary Artery Disease
- Shockwave Medical Coronary IVL System
- (no location specified)
Mar 2, 2023
Czech Pharmaco-epidemiological Study on Disease Modifying Drugs
Completed
- Multiple Sclerosis
- interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
-
Prague, CzechiaIMPULS Endowment Fund
Mar 7, 2023
Multiple Sclerosis Trial in Melsbroek
Completed
- Multiple Sclerosis
-
Melsbroek, Vlaams Brabant, BelgiumNationaal MS center
Apr 17, 2023
Lewy Body Disease, Healthy Aging Trial (transcranial direct current stimulation (tDCS))
Not yet recruiting
- Lewy Body Disease
- Healthy Aging
- transcranial direct current stimulation (tDCS)
- (no location specified)
Apr 26, 2023
Kesimpta Pregnancy and Infant Safety Study Using Real World Data
Not yet recruiting
- Multiple Sclerosis
- Multiple sclerosis disease modifying drug
- (no location specified)
Nov 27, 2023
Multiple Sclerosis COVID-19/Vaccination Treated With Ofatumumab
Completed
- Multiple Sclerosis
-
East Hanover, New JerseyNovartis
Jul 14, 2023
Antibody Response to COVID19 Vaccination in Multiple Sclerosis
Completed
- Multiple Sclerosis
- Covid19
-
Livingston, New JerseySaint Barnabas Medical Center
Aug 16, 2022
Parkinson's Disease Trial (Lithium aspartate)
Not yet recruiting
- Parkinson's Disease
- Lithium aspartate
- (no location specified)
Oct 27, 2023
Peyronie's Disease Trial
Not yet recruiting
- Peyronie's Disease
- (no location specified)
May 15, 2023
Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs
Completed
- Arthritis, Rheumatoid
-
Tokyo, JapanPfizer
Nov 28, 2022
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
MDS Trial (Fasting-mimicking diet (FMD) and physiotherapy)
Not yet recruiting
- Myelodysplastic Syndromes
- Fasting-mimicking diet (FMD) and physiotherapy
- (no location specified)
Jun 22, 2022
Disease Modifying Genes in Severe Asthma
Active, not recruiting
- Asthma
-
New York, New YorkNYU School of Medicine
Jan 11, 2022